Mesa Laboratories/$MLAB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Mesa Laboratories
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Ticker
$MLAB
Sector
Primary listing
Industry
Life Sciences Tools and Services
Headquarters
Employees
730
Website
MLAB Metrics
BasicAdvanced
$421M
-
-$0.36
0.89
$0.64
0.84%
Price and volume
Market cap
$421M
Beta
0.89
52-week high
$155.12
52-week low
$67.95
Average daily volume
189K
Dividend rate
$0.64
Financial strength
Current ratio
0.626
Quick ratio
0.433
Long term debt to equity
55.861
Total debt to equity
121.286
Interest coverage (TTM)
1.48%
Profitability
EBITDA (TTM)
42.095
Gross margin (TTM)
63.12%
Net profit margin (TTM)
-0.82%
Operating margin (TTM)
7.29%
Effective tax rate (TTM)
133.12%
Revenue per employee (TTM)
$330,000
Management effectiveness
Return on assets (TTM)
2.50%
Return on equity (TTM)
-1.29%
Valuation
Price to revenue (TTM)
1.72
Price to book
2.61
Price to tangible book (TTM)
-3.51
Price to free cash flow (TTM)
9.799
Free cash flow yield (TTM)
10.20%
Free cash flow per share (TTM)
7.805
Dividend yield (TTM)
0.84%
Forward dividend yield
0.84%
Growth
Revenue change (TTM)
11.47%
Earnings per share change (TTM)
-99.23%
3-year revenue growth (CAGR)
9.34%
10-year revenue growth (CAGR)
12.95%
3-year earnings per share growth (CAGR)
1.33%
10-year earnings per share growth (CAGR)
-17.94%
10-year dividend per share growth (CAGR)
0.32%
What the Analysts think about MLAB
Analyst ratings (Buy, Hold, Sell) for Mesa Laboratories stock.
Bulls say / Bears say
Mesa Laboratories reported a 5.5% increase in Q4 revenues to $62.1 million, with core organic revenue growth of 6.3%, indicating strong operational performance. (stocktitan.net)
The company successfully integrated GKE and launched Veridose 2.0, enhancing its product portfolio and market reach. (stocktitan.net)
Institutional investors like Ameriprise Financial Inc. increased their stake in Mesa Laboratories by 191.8% in Q4, reflecting confidence in the company's prospects. (marketbeat.com)
Despite revenue growth, Mesa Laboratories reported a net loss of $7.1 million in Q4, primarily due to increased performance-based compensation expenses. (stocktitan.net)
The company's debt-to-equity ratio stands at 0.61, which may raise concerns about financial leverage and interest obligations. (defenseworld.net)
CEO Gary M. Owens sold 21,000 shares in March 2025, potentially signaling a lack of confidence in the company's short-term stock performance. (marketbeat.com)
Data summarised monthly by Lightyear AI. Last updated on 10 Jul 2025.
MLAB Financial Performance
Revenues and expenses
MLAB Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Aug29
Mesa Laboratories
Dividend·Ex-dividend
Sept15
Mesa Laboratories
Dividend·Payment
$0.16Per share
FAQs
What’s the current market cap for Mesa Laboratories stock?
Mesa Laboratories (MLAB) has a market cap of $421M as of August 01, 2025.
What is the P/E ratio for Mesa Laboratories stock?
The price to earnings (P/E) ratio for Mesa Laboratories (MLAB) stock is 0 as of August 01, 2025.
Does Mesa Laboratories stock pay dividends?
Yes, the Mesa Laboratories (MLAB) stock pays dividends to shareholders. As of August 01, 2025, the dividend rate is $0.64 and the yield is 0.84%. Mesa Laboratories has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Mesa Laboratories dividend payment date?
The next Mesa Laboratories (MLAB) dividend payment is scheduled for September 15, 2025.
What is the beta indicator for Mesa Laboratories?
Mesa Laboratories (MLAB) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.